Literature DB >> 29564931

Long-term efficacy and safety after corneal collagen crosslinking in pediatric patients: Three-year follow-up.

Maria A Henriquez1, Sandra Villegas1, Mirel Rincon1, Carmen Maldonado1, Luis Izquierdo1.   

Abstract

PURPOSE: To evaluate the effectiveness of standard corneal collagen crosslinking for children with progressive keratoconus.
METHODS: Prospective study including 26 eyes of 26 patients younger than 18 years old with progressive keratoconus at Oftalmosalud Instituto de Ojos, Lima, Peru. Standard epi-off corneal crosslinking was performed in all eyes between January 2012 and January 2013. Pre- and postoperative evaluation (at 3 years) included uncorrected and best-corrected visual acuity and Scheimpflug analysis. Crosslinking failure was defined as an increase in maximum keratometry (Kmax) of more than 1 diopter after 1 year or more.
RESULTS: Mean uncorrected visual acuity improvement was 0.24 LogMAR (p = 0.07) and mean best-corrected visual acuity improvement was 0.18 LogMAR (p = 0.01). None of the eyes lost more than one line in the best-corrected visual acuity. Four eyes (15.38%) lost two lines in the uncorrected visual acuity at 3 years postoperative. Mean steeper keratometry improvement was 1.14 diopters (p = 0.60). Progression rate was 23.07%.
CONCLUSION: Standard epi-off corneal collagen crosslinking is safe and effective to halt the progression of the keratoconus with significant improvement in the best-corrected visual acuity at 3-year follow-up.

Entities:  

Keywords:  Crosslinking; children; keratoconus

Mesh:

Substances:

Year:  2018        PMID: 29564931     DOI: 10.1177/1120672118760149

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  9 in total

1.  Risk factors for progression following corneal collagen crosslinking in keratoconus.

Authors:  Ayhan Sağlık; Gökçen Özcan; Ömür Uçakhan
Journal:  Int Ophthalmol       Date:  2021-05-25       Impact factor: 2.031

2.  Differential Regional Stiffening of Sclera by Collagen Cross-linking.

Authors:  Bola A Gawargious; Alan Le; Michael Lesgart; Shoaib Ugradar; Joseph L Demer
Journal:  Curr Eye Res       Date:  2019-11-21       Impact factor: 2.424

3.  Comparative Results of "Epi-Off" Conventional versus "Epi-Off" Accelerated Cross-Linking Procedure at 5-year Follow-Up.

Authors:  Cristina Ariadna Nicula; Dorin Nicula; Anca Maria Rednik; Adriana Elena Bulboacă
Journal:  J Ophthalmol       Date:  2020-07-22       Impact factor: 1.909

4.  Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus.

Authors:  Ahmet Kirgiz; Mustafa Eliacik; Yusuf Yildirim
Journal:  Eye Vis (Lond)       Date:  2019-06-03

5.  Intracorneal Ring Segment Implantation for the Management of Keratoconus in Children.

Authors:  Pablo Larco; Pablo Larco; Daniel Torres; David P Piñero
Journal:  Vision (Basel)       Date:  2020-12-23

6.  Management Outcomes in Pediatric Keratoconus: Childhood Keratoconus Study.

Authors:  Yogita Gupta; Rohit Saxena; Vishal Jhanji; Prafulla K Maharana; Rajesh Sinha; Tushar Agarwal; Jeewan S Titiyal; Namrata Sharma
Journal:  J Ophthalmol       Date:  2022-02-07       Impact factor: 1.909

Review 7.  Pain mechanisms and management in corneal cross-linking: a review.

Authors:  Emilie Sophie van der Valk Bouman; Heather Pump; David Borsook; Boris Severinsky; Robert Pl Wisse; Hajirah N Saeed; Eric A Moulton
Journal:  BMJ Open Ophthalmol       Date:  2021-11-29

Review 8.  Pediatric Crosslinking: Current Protocols and Approach.

Authors:  Júlia Polido; Maria Emília Dos Xavier Santos Araújo; João G Alexander; Thiago Cabral; Renato Ambrósio; Denise Freitas
Journal:  Ophthalmol Ther       Date:  2022-04-28

9.  Baseline factors predicting the need for corneal crosslinking in patients with keratoconus.

Authors:  Naoko Kato; Kazuno Negishi; Chikako Sakai; Kazuo Tsubota
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.